Magnolia Medical Technologies, Inc. v. Kurin, Inc.
Patent Trial and Appeal Board
Holding
The Director denied institution of IPR2026-00097 (Magnolia Medical Technologies v. Kurin, Inc., U.S. Patent 12,138,052, medical device technology in Tech Center 3700) on discretionary grounds under § 314(a), concluding that the totality of the circumstances—including the parallel litigation posture, the public interest in preventing misuse of AIA reviews, and broader policy considerations regarding the IPR system's proper function—weighed against institution. The Director exercised discretion to deny institution notwithstanding the § 102 prior-art grounds raised by Petitioner, finding that the proceeding did not serve as a genuine alternative to district court litigation but rather as an additional forum for expanding invalidity arguments.
Why It Matters
This decision signals that the current Director is applying a robust, policy-driven § 314(a) discretionary denial framework that goes well beyond the traditional NHK-Fintiv factor-by-factor analysis, explicitly invoking Congressional intent, public interest, foreign-sovereign petitioner concerns, and systemic misuse of AIA reviews as independent bases for denial—practitioners should expect heightened scrutiny of petitions filed in parallel with litigation and should proactively address these broader policy considerations in petitions and opposition papers.
- Fed. Cir. · Sept. 30, 2026In re Medical Components, Inc.
- Fed. Cir. · Sept. 21, 2026In re Gomez
- Fed. Cir. · Sept. 14, 2026NCS Multistage Inc. v. TCO Group AS
- Fed. Cir. · Sept. 14, 2026NCS Multistage Inc. v. Nine Energy Service, Inc.
- PTAB Director Review · Sept. 9, 2026Samsung Electronics Co. Ltd. and Samsung Electronics America, Inc. v. Maxell, Ltd.